{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:01:53Z","timestamp":1760266913272,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.revmed.2008.10.012","type":"journal-article","created":{"date-parts":[[2008,11,21]],"date-time":"2008-11-21T05:41:29Z","timestamp":1227246089000},"page":"250-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fi\u00e8vre Q aigu\u00eb, antiphospholipides et thrombose art\u00e9rielle r\u00e9nale\u00a0: \u00e0 propos d\u2019un cas et revue de la litt\u00e9rature"],"prefix":"10.1016","volume":"30","author":[{"given":"Y.-M.","family":"Pers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Puygrenier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Borlot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Simorre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Barazer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Oziol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"Reny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2008.10.012_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1473-3099(05)70052-9","article-title":"Natural history and pathophysiology of Q fever","volume":"5","author":"Raoult","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.revmed.2008.10.012_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1128\/cdli.1.2.189-196.1994","article-title":"Q fever serology: cutoff determination for microimmunofluorescence","volume":"1","author":"Dupont","year":"1994","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.revmed.2008.10.012_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1086\/321889","article-title":"Risks factors and prevention of Q fever endocarditis","volume":"33","author":"Fenollar","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2008.10.012_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2008.10.012_bib5","first-page":"12","article-title":"The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome\u2013molecular mimicry?","volume":"27","author":"Asherson","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2008.10.012_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1023\/B:JOCI.0000018058.28764.ce","article-title":"Antiphospholipid syndrome infectious origin","volume":"24","author":"Blank","year":"2004","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.revmed.2008.10.012_bib7","first-page":"ECR12","article-title":"Autoimmune type antiphospholipid antibodies in a patient with Q fever","volume":"90","author":"Aguilar","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2008.10.012_bib8","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2003.014175","article-title":"Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients","volume":"63","author":"Cervera","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2008.10.012_bib9","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.medmal.2005.08.004","article-title":"Infections associated to severe thrombotic events and antiphospholipid antibodies","volume":"35","author":"Vidal","year":"2005","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.revmed.2008.10.012_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/clinids\/18.2.213","article-title":"Prevalence, significance, and specificity of antibodies to phospholipids in Q fever","volume":"18","author":"Ordi-Ros","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2008.10.012_bib11","first-page":"454","article-title":"Q fever and anticardiolipin antibodies","volume":"191","author":"Campos-Alvarez","year":"1992","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.revmed.2008.10.012_bib12","first-page":"256","article-title":"Antiphospholipid antibodies in Q fever","volume":"8","author":"Grau Martin","year":"1991","journal-title":"An Med Interna"},{"key":"10.1016\/j.revmed.2008.10.012_bib13","first-page":"1321","article-title":"Anticardiolipin antibodies and dependence of a serum cofactor. A mechanism of thrombosis","volume":"20","author":"Ordi","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2008.10.012_bib14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/ard.2005.045443","article-title":"Infectious origin of the antiphospholipid syndrome","volume":"65","author":"Shoenfeld","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2008.10.012_bib15","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.4049\/jimmunol.173.10.5901","article-title":"Tlr signaling: an emerging bridge from innate immunity to atherogenesis","volume":"173","author":"Michelsen","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2008.10.012_bib16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.lpm.2006.11.013","article-title":"Pathogenesis of the antiphospholipid syndrome","volume":"36","author":"Pasquali","year":"2007","journal-title":"Presse Med"},{"issue":"Suppl 1","key":"10.1016\/j.revmed.2008.10.012_bib17","article-title":"Ttherapeutic use of intravenous immunoglobulins in the antiphospholipid syndrome","volume":"151","author":"Piette","year":"2000","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.revmed.2008.10.012_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.autrev.2006.06.008","article-title":"New subsets of the antiphospholipid syndrome in 2006: \u201cpre-aps\u201d (probable aps) and microangiopathic antiphospholipid syndromes (MAPS)","volume":"6","author":"Asherson","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2008.10.012_bib19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.autrev.2006.06.005","article-title":"The catastrophic antiphospholipid (Asherson's) syndrome","volume":"6","author":"Asherson","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2008.10.012_bib20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.autrev.2006.06.013","article-title":"Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome","volume":"6","author":"Erkan","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2008.10.012_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1078\/0171-2985-00212","article-title":"Antiphospholipid antibodies: Are they pro-atherogenic or an epiphenomenon of atherosclerosis?","volume":"207","author":"Sherer","year":"2003","journal-title":"Immunobiology"},{"key":"10.1016\/j.revmed.2008.10.012_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1078\/0171-2985-00211","article-title":"Endothelium as a target for antiphospholipid antibodies","volume":"207","author":"Riboldi","year":"2003","journal-title":"Immunobiology"},{"key":"10.1016\/j.revmed.2008.10.012_bib23","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/1529-0131(200112)44:12<2870::AID-ART475>3.0.CO;2-Y","article-title":"Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein i) antibodies: effect on the proadhesive and proinflammatory phenotype","volume":"44","author":"Meroni","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2008.10.012_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.revmed.2006.12.014","article-title":"First joint French-British symposium on antiphospholipid Hughes'syndrome","volume":"28","author":"Magy-Bertrand","year":"2007","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2008.10.012_bib25","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/ard.2006.067314","article-title":"Assessment of the 2006 revised antiphospholipid syndrome classification criteria","volume":"66","author":"Kaul","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2008.10.012_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.autrev.2006.06.009","article-title":"Lessons from the catastrophic antiphospholipid syndrome (CAPS) registry","volume":"6","author":"Cervera","year":"2006","journal-title":"Autoimmun Rev"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866308008722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866308008722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:23:24Z","timestamp":1759335804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866308008722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0248866308008722"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2008.10.012","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fi\u00e8vre Q aigu\u00eb, antiphospholipides et thrombose art\u00e9rielle r\u00e9nale\u00a0: \u00e0 propos d\u2019un cas et revue de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2008.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}